DGX Annual CFF
$160.00 M
+$1.89 B+109.24%
31 December 2023
Summary:
As of January 22, 2025, DGX annual cash flow from financing activities is $160.00 million, with the most recent change of +$1.89 billion (+109.24%) on December 31, 2023. During the last 3 years, it has risen by +$1.43 billion (+112.63%). DGX annual CFF is now -81.18% below its all-time high of $850.22 million, reached on December 31, 2007.DGX Cash From Financing Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
DGX Quarterly CFF
$1.77 B
+$2.13 B+587.60%
30 September 2024
Summary:
As of January 22, 2025, DGX quarterly cash flow from financing activities is $1.77 billion, with the most recent change of +$2.13 billion (+587.60%) on September 30, 2024. Over the past year, it has increased by +$1.64 billion (+1261.54%). DGX quarterly CFF is now at all-time high.DGX Quarterly CFF Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
DGX TTM CFF
$1.38 B
+$1.85 B+395.10%
30 September 2024
Summary:
As of January 22, 2025, DGX TTM cash flow from financing activities is $1.38 billion, with the most recent change of +$1.85 billion (+395.10%) on September 30, 2024. Over the past year, it has increased by +$1.22 billion (+765.00%). DGX TTM CFF is now at all-time high.DGX TTM CFF Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
DGX Cash From Financing Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | +109.2% | +1261.5% | +765.0% |
| 3 y3 years | +112.6% | +1261.5% | +765.0% |
| 5 y5 years | +139.9% | +1261.5% | +765.0% |
DGX Cash From Financing High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | at high | +106.3% | at high | +424.8% | at high | +154.5% |
| 5 y | 5-year | -28.9% | +106.3% | at high | +212.9% | at high | +146.1% |
| alltime | all time | -81.2% | +106.3% | at high | +212.9% | at high | +146.1% |
Quest Diagnostics Incorporated Cash From Financing History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sept 2024 | - | $1.77 B(-587.6%) | $1.38 B(-395.1%) |
| June 2024 | - | -$363.00 M(+137.3%) | -$469.00 M(-665.1%) |
| Mar 2024 | - | -$153.00 M(-217.7%) | $83.00 M(-48.1%) |
| Dec 2023 | $160.00 M(-109.2%) | $130.00 M(-256.6%) | $160.00 M(-131.1%) |
| Sept 2023 | - | -$83.00 M(-143.9%) | -$515.00 M(-43.2%) |
| June 2023 | - | $189.00 M(-348.7%) | -$906.00 M(-32.2%) |
| Mar 2023 | - | -$76.00 M(-86.1%) | -$1.34 B(-22.8%) |
| Dec 2022 | -$1.73 B(-31.8%) | -$545.00 M(+15.0%) | -$1.73 B(+11.3%) |
| Sept 2022 | - | -$474.00 M(+95.9%) | -$1.56 B(+38.9%) |
| June 2022 | - | -$242.00 M(-48.6%) | -$1.12 B(-54.2%) |
| Mar 2022 | - | -$471.00 M(+27.6%) | -$2.44 B(-3.7%) |
| Dec 2021 | -$2.54 B(+100.5%) | -$369.00 M(+871.1%) | -$2.54 B(-15.1%) |
| Sept 2021 | - | -$38.00 M(-97.6%) | -$2.99 B(-0.5%) |
| June 2021 | - | -$1.57 B(+176.9%) | -$3.00 B(+219.0%) |
| Mar 2021 | - | -$566.00 M(-31.0%) | -$942.00 M(-25.7%) |
| Dec 2020 | -$1.27 B(-663.1%) | -$820.00 M(+1476.9%) | -$1.27 B(-2111.1%) |
| Sept 2020 | - | -$52.00 M(-110.5%) | $63.00 M(-26.7%) |
| June 2020 | - | $496.00 M(-155.7%) | $86.00 M(-110.4%) |
| Mar 2020 | - | -$891.00 M(-274.7%) | -$830.00 M(-468.9%) |
| Dec 2019 | $225.00 M(-156.1%) | $510.00 M(-1858.6%) | $225.00 M(-162.2%) |
| Sept 2019 | - | -$29.00 M(-93.1%) | -$362.00 M(-24.4%) |
| June 2019 | - | -$420.00 M(-356.1%) | -$479.00 M(+93.1%) |
| Mar 2019 | - | $164.00 M(-313.0%) | -$248.00 M(-38.2%) |
| Dec 2018 | -$401.00 M(-32.3%) | -$77.00 M(-47.3%) | -$401.00 M(-18.8%) |
| Sept 2018 | - | -$146.00 M(-22.8%) | -$494.00 M(+15.7%) |
| June 2018 | - | -$189.00 M(-1818.2%) | -$427.00 M(+2.9%) |
| Mar 2018 | - | $11.00 M(-106.5%) | -$415.00 M(-29.9%) |
| Dec 2017 | -$592.00 M(-19.8%) | -$170.00 M(+115.2%) | -$592.00 M(-17.0%) |
| Sept 2017 | - | -$79.00 M(-55.4%) | -$713.00 M(-3.6%) |
| June 2017 | - | -$177.00 M(+6.6%) | -$740.00 M(-20.9%) |
| Mar 2017 | - | -$166.00 M(-43.0%) | -$936.00 M(+26.8%) |
| Dec 2016 | -$738.00 M(+42.5%) | -$291.00 M(+174.5%) | -$738.00 M(+26.4%) |
| Sept 2016 | - | -$106.00 M(-71.6%) | -$584.00 M(-3.2%) |
| June 2016 | - | -$373.00 M(-1265.6%) | -$603.00 M(-52.6%) |
| Mar 2016 | - | $32.00 M(-123.4%) | -$1.27 B(+145.4%) |
| Dec 2015 | -$518.00 M(-702.3%) | -$137.00 M(+9.6%) | -$518.00 M(-10.2%) |
| Sept 2015 | - | -$125.00 M(-88.0%) | -$577.00 M(-4.5%) |
| June 2015 | - | -$1.04 B(-232.6%) | -$604.00 M(-266.9%) |
| Mar 2015 | - | $785.00 M(-500.5%) | $362.00 M(+320.9%) |
| Dec 2014 | $86.00 M(-107.8%) | -$196.00 M(+28.9%) | $86.00 M(-58.3%) |
| Sept 2014 | - | -$152.00 M(+102.7%) | $206.00 M(-176.0%) |
| June 2014 | - | -$75.00 M(-114.7%) | -$271.00 M(-49.5%) |
| Mar 2014 | - | $509.00 M(-769.7%) | -$537.00 M(-51.4%) |
| Dec 2013 | -$1.11 B(+34.5%) | -$76.00 M(-87.9%) | -$1.11 B(-11.3%) |
| Sept 2013 | - | -$629.00 M(+84.5%) | -$1.25 B(+31.2%) |
| June 2013 | - | -$341.00 M(+468.3%) | -$950.26 M(+21.1%) |
| Mar 2013 | - | -$60.00 M(-72.4%) | -$784.53 M(-4.6%) |
| Dec 2012 | -$822.00 M(-1384.4%) | -$217.12 M(-34.6%) | -$822.00 M(-2.9%) |
| Sept 2012 | - | -$332.14 M(+89.5%) | -$846.74 M(+15.7%) |
| June 2012 | - | -$175.27 M(+79.8%) | -$731.54 M(+59.5%) |
| Mar 2012 | - | -$97.47 M(-59.7%) | -$458.58 M(-816.5%) |
| Dec 2011 | $64.00 M(-106.5%) | -$241.85 M(+11.5%) | $64.00 M(-48.0%) |
| Sept 2011 | - | -$216.95 M(-322.1%) | $122.98 M(-686.1%) |
| June 2011 | - | $97.69 M(-77.0%) | -$20.98 M(-92.9%) |
| Mar 2011 | - | $425.11 M(-332.5%) | -$293.74 M(-70.2%) |
| Dec 2010 | -$986.49 M | -$182.87 M(-49.3%) | -$986.49 M(+20.2%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sept 2010 | - | -$360.91 M(+106.2%) | -$821.00 M(+24.4%) |
| June 2010 | - | -$175.07 M(-34.6%) | -$659.78 M(+29.9%) |
| Mar 2010 | - | -$267.64 M(+1439.5%) | -$507.72 M(-2.6%) |
| Dec 2009 | -$521.20 M(-33.0%) | -$17.39 M(-91.3%) | -$521.20 M(-36.2%) |
| Sept 2009 | - | -$199.69 M(+767.9%) | -$817.07 M(+8.1%) |
| June 2009 | - | -$23.01 M(-91.8%) | -$755.51 M(-17.9%) |
| Mar 2009 | - | -$281.12 M(-10.3%) | -$920.68 M(+18.4%) |
| Dec 2008 | -$777.81 M(-191.5%) | -$313.25 M(+126.8%) | -$777.81 M(+9.9%) |
| Sept 2008 | - | -$138.12 M(-26.6%) | -$707.86 M(-4.8%) |
| June 2008 | - | -$188.18 M(+36.1%) | -$743.78 M(-246.2%) |
| Mar 2008 | - | -$138.26 M(-43.2%) | $508.81 M(-40.2%) |
| Dec 2007 | $850.22 M(-277.1%) | -$243.30 M(+39.8%) | $850.22 M(-5.0%) |
| Sept 2007 | - | -$174.05 M(-116.4%) | $895.10 M(-15.9%) |
| June 2007 | - | $1.06 B(+424.0%) | $1.06 B(-928.4%) |
| Mar 2007 | - | $203.15 M(-202.4%) | -$128.50 M(-73.2%) |
| Dec 2006 | -$479.98 M(-294.3%) | -$198.42 M(+4129.0%) | -$479.98 M(-448.1%) |
| Sept 2006 | - | -$4.69 M(-96.3%) | $137.88 M(+220.5%) |
| June 2006 | - | -$128.53 M(-13.4%) | $43.02 M(-70.7%) |
| Mar 2006 | - | -$148.34 M(-135.4%) | $146.68 M(-40.6%) |
| Dec 2005 | $247.04 M(-135.0%) | $419.44 M(-521.3%) | $247.04 M(-147.5%) |
| Sept 2005 | - | -$99.56 M(+300.3%) | -$519.78 M(-2.5%) |
| June 2005 | - | -$24.87 M(-48.2%) | -$533.28 M(-26.4%) |
| Mar 2005 | - | -$47.98 M(-86.2%) | -$724.60 M(+2.5%) |
| Dec 2004 | -$706.74 M(+276.8%) | -$347.38 M(+207.3%) | -$706.74 M(+40.7%) |
| Sept 2004 | - | -$113.06 M(-47.7%) | -$502.35 M(-3.1%) |
| June 2004 | - | -$216.18 M(+617.8%) | -$518.41 M(+31.3%) |
| Mar 2004 | - | -$30.12 M(-78.9%) | -$394.70 M(+110.4%) |
| Dec 2003 | -$187.57 M(+29.6%) | -$142.99 M(+10.7%) | -$187.57 M(-30.7%) |
| Sept 2003 | - | -$129.12 M(+39.6%) | -$270.67 M(+24.2%) |
| June 2003 | - | -$92.47 M(-152.2%) | -$217.85 M(-945.8%) |
| Mar 2003 | - | $177.01 M(-178.3%) | $25.76 M(-117.8%) |
| Dec 2002 | -$144.71 M(-33.7%) | -$226.09 M(+196.3%) | -$144.71 M(+160.0%) |
| Sept 2002 | - | -$76.30 M(-150.5%) | -$55.66 M(+72.3%) |
| June 2002 | - | $151.13 M(+2209.5%) | -$32.29 M(-84.7%) |
| Mar 2002 | - | $6.54 M(-104.8%) | -$210.58 M(-3.6%) |
| Dec 2001 | -$218.33 M(+23.2%) | -$137.04 M(+158.9%) | -$218.33 M(-7.9%) |
| Sept 2001 | - | -$52.93 M(+95.0%) | -$237.02 M(+27.6%) |
| June 2001 | - | -$27.15 M(+2143.8%) | -$185.74 M(+11.2%) |
| Mar 2001 | - | -$1.21 M(-99.2%) | -$166.98 M(-5.8%) |
| Dec 2000 | -$177.25 M(-126.0%) | -$155.72 M(+9297.8%) | -$177.25 M(+147.1%) |
| Sept 2000 | - | -$1.66 M(-80.3%) | -$71.72 M(-109.8%) |
| June 2000 | - | -$8.39 M(-26.9%) | $734.03 M(+1.2%) |
| Mar 2000 | - | -$11.48 M(-77.1%) | $725.61 M(+6.3%) |
| Dec 1999 | $682.80 M(-1230.5%) | -$50.20 M(-106.2%) | $682.80 M(-6.3%) |
| Sept 1999 | - | $804.10 M(-4881.2%) | $729.00 M(-823.2%) |
| June 1999 | - | -$16.82 M(-69.0%) | -$100.80 M(-5.6%) |
| Mar 1999 | - | -$54.28 M(+1257.0%) | -$106.78 M(+76.8%) |
| Dec 1998 | -$60.40 M(+180.9%) | -$4.00 M(-84.4%) | -$60.40 M(+4.7%) |
| Sept 1998 | - | -$25.70 M(+12.7%) | -$57.70 M(+79.8%) |
| June 1998 | - | -$22.80 M(+188.6%) | -$32.10 M(+237.9%) |
| Mar 1998 | - | -$7.90 M(+507.7%) | -$9.50 M(-55.8%) |
| Dec 1997 | -$21.50 M(-113.6%) | -$1.30 M(+1200.0%) | -$21.50 M(+6.4%) |
| Sept 1997 | - | -$100.00 K(-50.0%) | -$20.20 M(+0.5%) |
| June 1997 | - | -$200.00 K(-99.0%) | -$20.10 M(+1.0%) |
| Mar 1997 | - | -$19.90 M | -$19.90 M |
| Dec 1996 | $157.67 M | - | - |
FAQ
- What is Quest Diagnostics Incorporated annual cash flow from financing activities?
- What is the all time high annual CFF for Quest Diagnostics Incorporated?
- What is Quest Diagnostics Incorporated annual CFF year-on-year change?
- What is Quest Diagnostics Incorporated quarterly cash flow from financing activities?
- What is the all time high quarterly CFF for Quest Diagnostics Incorporated?
- What is Quest Diagnostics Incorporated quarterly CFF year-on-year change?
- What is Quest Diagnostics Incorporated TTM cash flow from financing activities?
- What is the all time high TTM CFF for Quest Diagnostics Incorporated?
- What is Quest Diagnostics Incorporated TTM CFF year-on-year change?
What is Quest Diagnostics Incorporated annual cash flow from financing activities?
The current annual CFF of DGX is $160.00 M
What is the all time high annual CFF for Quest Diagnostics Incorporated?
Quest Diagnostics Incorporated all-time high annual cash flow from financing activities is $850.22 M
What is Quest Diagnostics Incorporated annual CFF year-on-year change?
Over the past year, DGX annual cash flow from financing activities has changed by +$1.89 B (+109.24%)
What is Quest Diagnostics Incorporated quarterly cash flow from financing activities?
The current quarterly CFF of DGX is $1.77 B
What is the all time high quarterly CFF for Quest Diagnostics Incorporated?
Quest Diagnostics Incorporated all-time high quarterly cash flow from financing activities is $1.77 B
What is Quest Diagnostics Incorporated quarterly CFF year-on-year change?
Over the past year, DGX quarterly cash flow from financing activities has changed by +$1.64 B (+1261.54%)
What is Quest Diagnostics Incorporated TTM cash flow from financing activities?
The current TTM CFF of DGX is $1.38 B
What is the all time high TTM CFF for Quest Diagnostics Incorporated?
Quest Diagnostics Incorporated all-time high TTM cash flow from financing activities is $1.38 B
What is Quest Diagnostics Incorporated TTM CFF year-on-year change?
Over the past year, DGX TTM cash flow from financing activities has changed by +$1.22 B (+765.00%)